SBL
HOOK

Sargent Bickham Lagudis’s HOOKIPA Pharma HOOK Stock Holding History

Sargent Bickham Lagudis’s Portfolio HOOK Stock Details HOOK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-10
Closed -$1K – 955
2021
Q1 		$1K Hold
10
– – ﹤0.01% 893
2020
Q4 		$1K Buy
+10
New +$1.08K ﹤0.01% 836

Other funds holding HOOK

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Sargent Bickham Lagudis's HOOK Position: Q2 2021 in Review

Sargent Bickham Lagudis sold out of HOOKIPA Pharma (HOOK) in Q2 2021, closing a stake of 10 shares — an estimated $1K sold.

Sargent Bickham Lagudis first reported a position in HOOK in Q4 2020 and held it in 2 quarters. The position peaked at $1K in Q1 2021. 71 funds tracked by Wall St. Rank hold HOOK as of Q2 2021.

  • Sargent Bickham Lagudis reported no remaining HOOKIPA Pharma position as of Q2 2021 after selling out during the quarter.
  • Sargent Bickham Lagudis sold 10 HOOKIPA Pharma shares in Q2 2021, an estimated $1K.
  • Sargent Bickham Lagudis first reported a position in HOOKIPA Pharma in Q4 2020 and held it in 2 quarters.
  • Sargent Bickham Lagudis's HOOKIPA Pharma position peaked at $1K in Q1 2021.
  • 71 funds tracked by Wall St. Rank held HOOKIPA Pharma as of Q2 2021.

Based on Sargent Bickham Lagudis's 13F filing for Q2 2021, filed 19 Jul 2021.